CYTR - CytRx Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.87
-0.04 (-2.09%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close1.91
Open1.88
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.87 - 1.99
52 Week Range1.71 - 6.00
Volume252,009
Avg. Volume356,378
Market Cap51.682M
Beta1.59
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Presslast month

    CytRx reports 3Q loss

    On a per-share basis, the Los Angeles-based company said it had a loss of 19 cents. Losses, adjusted for non-recurring gains, were 33 cents per share. The company's shares closed at $1.93. A year ago, ...

  • Is CytRx Corporation’s (CYTR) Balance Sheet A Threat To Its Future?
    Simply Wall St.last month

    Is CytRx Corporation’s (CYTR) Balance Sheet A Threat To Its Future?

    CytRx Corporation (NASDAQ:CYTR) is a small-cap stock with a market capitalization of USD $59.70M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...

  • Associated Press4 months ago

    CytRx reports 2Q loss

    The Los Angeles-based company said it had a loss of 10 cents per share. Losses, adjusted for non-recurring costs, came to 7 cents per share. The company's shares closed at 80 cents. A year ago, they were ...

  • 4 Biotech Stocks to Watch This Quarter
    GuruFocus.com4 months ago

    4 Biotech Stocks to Watch This Quarter

    Biotech could easily continue to grow as long-term trends remain in place

  • Investopedia5 months ago

    Penny Stocks to Watch for June 2017 (CYTR, DELT)

    These ten penny stocks trading on U.S. public exchanges could gain substantial ground in 2017.

  • TheStreet.com6 months ago

    Goodbye CytRx, Your Game Is Over

    Hope springs eternal, until it's dashed on the rocks and buried at sea.

  • Investopedia6 months ago

    Penny Stocks to Watch for June 2017

    These ten penny stocks trading on U.S. public exchanges could gain substantial ground in June 2017 and the coming months.

  • Benzinga7 months ago

    The Most Notable Abstracts Released Ahead Of ASCO 2017

    The American Society of Clinical Oncology, or ASCO, has scheduled its annual meeting on June 2–6, 2017, at McCormick Place, Chicago. The five-day event has Conquer Cancer Foundation as its lead sponsor. ...

  • Associated Press7 months ago

    CytRx reports 1Q loss

    On a per-share basis, the Los Angeles-based company said it had a loss of 10 cents. The company's shares closed at 46 cents. A year ago, they were trading at $3.07. _____ This story was generated by Automated ...

  • Investopedia8 months ago

    Penny Stocks to Watch for May 2017

    These ten penny stocks trading on U.S. public exchanges could gain substantial ground in April 2017 and the coming months.

  • CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up
    Zacks8 months ago

    CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up

    CytRx Corporation (CYTR) announced that the it has reached an agreement with the regarding the path to filing for its new drug application (NDA) for its lead candidate aldoxorubicin being developed for the treatment of soft tissue sarcomas (STS).

  • Capital Cube8 months ago

    ETFs with exposure to CytRx Corp. : April 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CytRx Corp. Here are 5 ETFs with the largest exposure to CYTR-US. Comparing the performance and risk of CytRx Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • TheStreet.com8 months ago

    For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

    An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.

  • Capital Cube8 months ago

    ETFs with exposure to CytRx Corp. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CytRx Corp. Here are 5 ETFs with the largest exposure to CYTR-US. Comparing the performance and risk of CytRx Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • CytRx Corp. :CYTR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube9 months ago

    CytRx Corp. :CYTR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis CytRx Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of CytRx Corp. – Amgen Inc., Novartis AG Sponsored ADR, Curis, Inc., GlaxoSmithKline plc Sponsored ADR, Celldex Therapeutics, Inc., Aeolus Pharmaceuticals, Inc., Seattle Genetics, Inc. and Celgene Corporation (AMGN-US, NVS-US, ... Read more (Read more...)

  • TheStreet.com9 months ago

    The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

    The firms all have drugs they want the feds to bend the rules to approve.

  • Zacks11 months ago

    Is the Options Market Predicting a Spike in CytRx Corp (CYTR) Stock?

    Options traders are pricing in a big move for CytRx Corp (CYTR) shares as it has huge implied volatility

  • How CytRx Corporation (CYTR) Stacks Up Against Its Peers
    Insider Monkeylast year

    How CytRx Corporation (CYTR) Stacks Up Against Its Peers

    The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge funds have been producing disappointing net returns in recent years, however that was partly due to the poor performance of small-cap stocks in general. […]